Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
Global Clot Management Devices Industry (2019 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
12:00am, Thursday, 02'nd Jul 2020
The
3 Companies With Stellar Balance Sheets Set To Thrive For The Next Decade
05:30pm, Wednesday, 01'st Jul 2020
Cash is king, especially during a pandemic. A combination of strong cash flow and low debt is a recipe for success in 2020. I've identified 3 strong dividend st
Zacks: Analysts Anticipate LeMaitre Vascular Inc (NASDAQ:LMAT) Will Announce Quarterly Sales of $15.58 Million
05:50am, Friday, 26'th Jun 2020
Wall Street brokerages expect LeMaitre Vascular Inc (NASDAQ:LMAT) to post $15.58 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for LeMaitre Vas
LeMaitre Vascular: Looking Fair
08:06pm, Thursday, 25'th Jun 2020
LeMaitre Vascular has been underrated a long time, but perhaps overvalued last year. Following a big pullback, shares now appear to be trading around fair value
Head to Head Contrast: LeMaitre Vascular (NASDAQ:LMAT) versus SeaSpine (NASDAQ:SPNE)
03:12am, Thursday, 25'th Jun 2020
LeMaitre Vascular (NASDAQ:LMAT) and SeaSpine (NASDAQ:SPNE) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earn
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
LeMaitre Vascular Acquires Artegraft
08:13pm, Monday, 22'nd Jun 2020
LeMaitre Vascular, Inc. (LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft
LeMaitre Vascular Acquires Artegraft
12:00am, Monday, 22'nd Jun 2020
BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of...
The global deep brain stimulation devices market size is expected to reach USD 1,676.8 million by 2026, exhibiting a CAGR of 11.6% during the forecast
LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by BidaskClub
03:22am, Monday, 15'th Jun 2020
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Saturday, BidAskClub reports. A number of othe
LeMaitre Vascular Inc (LMAT): Hedge Funds Are Turning Bearish
08:28pm, Friday, 12'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
COVID-19 Impact and Recovery Analysis- Aortic Stent Grafts Market 2020-2024 | Rising Preference for EVAR to Boost Growth | Technavio
12:00am, Thursday, 11'th Jun 2020
The Global Aortic Stent Grafts Market will grow by USD 690.09 mn during 2020-2024
A Look Into LeMaitre Vascular's Price Over Earnings
06:44pm, Tuesday, 09'th Jun 2020
In the current market session, LeMaitre Vascular Inc. (NASDAQ: LMAT) is trading at $27.29, after a 2.36% decrease. However, over the past month, the stock increased by 3.92%, and in the past year, by
Admedus Changes Name to Anteris Technologies Ltd
09:30am, Monday, 01'st Jun 2020
Admedus Limited (ASX:AHZ), announced today that it has changed the Company’s name to Anteris Technologies Ltd (“Anteris”). As of May 22, 2020 Anteris, is trading on the Australian Securities Ex
Dividend Champion And Contender Highlights: Week Of May 31
11:06am, Sunday, 31'st May 2020
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
